Company Analysis CanSino Biologics Inc.
1. Summary
Advantages
- Price (36.26 HK$) is less than fair price (40.81 HK$)
Disadvantages
- Dividends (0%) are below the sector average (1.61%).
- The stock's return over the last year (22.92%) is lower than the sector average (45.69%).
- Current debt level 25.32% has increased over 5 years from 1.93%.
- The company's current efficiency (ROE=-6.87%) is lower than the sector average (ROE=-5.11%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| CanSino Biologics Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 3.8% | 0.6% | 2.8% |
| 90 days | -21.6% | -3.5% | -2.3% |
| 1 year | 22.9% | 45.7% | 33.3% |
6185 vs Sector: CanSino Biologics Inc. has significantly underperformed the "Healthcare" sector by -22.78% over the past year.
6185 vs Market: CanSino Biologics Inc. has significantly underperformed the market by -10.42% over the past year.
Stable price: 6185 is not significantly more volatile than the rest of the market on "Hong Kong Exchanges" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 6185 with weekly volatility of 0.4407% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Below fair price: The current price (36.26 HK$) is lower than the fair price (40.81 HK$).
Price not significantly lower than the fair price: The current price (36.26 HK$) is slightly lower than the fair price by 12.5%.
5.2. P/E
P/E vs Sector: The company's P/E (-31.08) is lower than that of the sector as a whole (-28.02).
P/E vs Market: The company's P/E (-31.08) is lower than that of the market as a whole (65.27).
5.3. P/BV
P/BV vs Sector: The company's P/BV (1.51) is lower than that of the sector as a whole (3.04).
P/BV vs Market: The company's P/BV (1.51) is lower than that of the market as a whole (5.74).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (9.32) is lower than that of the sector as a whole (54.93).
P/S vs Market: The company's P/S indicator (9.32) is lower than that of the market as a whole (20.78).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-62.1) is lower than that of the sector as a whole (29.1).
EV/Ebitda vs Market: The company's EV/Ebitda (-62.1) is lower than that of the market as a whole (38.03).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -23.66% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-23.66%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-10.17%).
6.4. ROE
ROE vs Sector: The company's ROE (-6.87%) is lower than that of the sector as a whole (-5.11%).
ROE vs Market: The company's ROE (-6.87%) is lower than that of the market as a whole (2.83%).
6.6. ROA
ROA vs Sector: The company's ROA (-4.05%) is lower than that of the sector as a whole (0.2787%).
ROA vs Market: The company's ROA (-4.05%) is lower than that of the market as a whole (2.72%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (14.67%).
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.61%.
8.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.5.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.
8.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
Based on sources: porti.ru
